Concepedia

Publication | Open Access

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

DOIFull Paper Access

60

Citations

16

References

2021

Year

Jacqueline A. Pongracic, Rémi Gagnon, Gordon L. Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn, Todd D. Green, Dianne E. Campbell, Sara Anvari, William E. Berger,
The Journal of Allergy and Clinical Immunology In Practice

Abstract

In a study designed to mirror real-world use, VP250 was observed to be well tolerated in peanut-allergic children, consistent with previous phase 2b and 3 studies.

References

YearCitations

Page 1